穴位埋线治疗腹泻型肠易激综合征和便秘型肠易激综合征的疗效与安全性:一项系统评价和Meta分析

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

作者信息

Wu Jing, Fu Qinwei, Yang Shasha, Wang Hui, Li Yaofeng

机构信息

Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.

Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.

出版信息

Evid Based Complement Alternat Med. 2020 Nov 27;2020:5812320. doi: 10.1155/2020/5812320. eCollection 2020.

Abstract

In this study, we aim to evaluate the efficacy and safety of acupoint catgut embedding for the treatment of diarrhea-predominant irritable bowel syndrome and constipation-predominant irritable bowel syndrome. We searched seven online databases to collect studies published up to Feb 29, 2020. Study quality of each included article was evaluated by the Cochrane Collaboration Risk of Bias Tool. Systematic reviews and meta-analyses were conducted based on the Cochrane systematic review method by using RevMan 5.3 software. Among the included trials, acupoint catgut embedding alone or plus oral western medicine or plus other acupoint-based therapies, or plus oral traditional Chinese medicine were the main therapies in the experimental groups. Interventions in control groups mainly include oral western medicine alone, other acupoint-based therapies alone, or other acupoint-based therapies alone. Primary outcomes in this study include recovery rate, accumulative marked effective rate, accumulative effective rate, and recurrence rate. Finally, 30 trials involving 1889 participants were included. The results of systematic reviews and meta-analyses show that acupoint catgut embedding alone or plus oral western medicine or plus other acupoint-based therapy or plus oral traditional Chinese medicine was significantly better compared with using oral western medicine alone in terms of efficacy for IBS-C and IBS-D. In addition, acupoint catgut embedding alone or plus oral western medicine or plus other acupoint-based therapy or plus oral traditional Chinese medicine could improve the effective rate and decrease the recurrence rate for IBS-D compared with using oral western medicine, other acupoint-based therapies, or oral traditional Chinese medicine alone. Adverse events of acupoint catgut embedding include local induration, redness, swelling, and itchiness, but they were all mild and disappeared swiftly with ordinary local interventions. There is an urgent need for RCTs of high quality and large sample size and with longer treatment duration and follow-up periods of acupoint catgut embedding for IBS.

摘要

在本研究中,我们旨在评估穴位埋线治疗腹泻型肠易激综合征和便秘型肠易激综合征的疗效及安全性。我们检索了七个在线数据库,以收集截至2020年2月29日发表的研究。每篇纳入文章的研究质量由Cochrane协作网偏倚风险工具进行评估。采用RevMan 5.3软件,基于Cochrane系统评价方法进行系统评价和Meta分析。在纳入的试验中,穴位埋线单独使用、或联合口服西药、或联合其他穴位疗法、或联合口服中药是实验组的主要治疗方法。对照组的干预措施主要包括单独口服西药、单独使用其他穴位疗法、或单独使用其他穴位疗法。本研究的主要结局指标包括治愈率、累计显效率、累计有效率和复发率。最终,纳入了30项试验,涉及1889名参与者。系统评价和Meta分析结果显示,在治疗便秘型肠易激综合征和腹泻型肠易激综合征的疗效方面,穴位埋线单独使用、或联合口服西药、或联合其他穴位疗法、或联合口服中药显著优于单独使用口服西药。此外,与单独使用口服西药、其他穴位疗法或口服中药相比,穴位埋线单独使用、或联合口服西药、或联合其他穴位疗法、或联合口服中药可提高腹泻型肠易激综合征的有效率并降低复发率。穴位埋线的不良事件包括局部硬结、发红、肿胀和瘙痒,但均较轻微,经普通局部干预后迅速消失。迫切需要开展高质量、大样本量、更长治疗疗程和随访期的穴位埋线治疗肠易激综合征的随机对照试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3913/7735853/b4029ed160c5/ECAM2020-5812320.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索